Novo Nordisk AS
A3EU6F
DK0062498333 //
Quelle: CPH Equities: 04.08.2026, 17:02:43
307,60 DKK
Kurs
Kurs
1,75%
Diff. Vortag in %
Diff. Vortag in %
224,25 DKK
52 Wochen Tief
52 Wochen Tief
409,95 DKK
52 Wochen Hoch
52 Wochen Hoch
- Neutral
- Seit dem 07.07.2026
- Informationen von thescreener.com
Tools
Fundamentalanalyse
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 04.08.2026 12 Monate | 04.08.2026 | 12 Monate | 307,60 285 | 307,60 | 285 | 7,347204 | JEFFERIES | ||
| Novo Nordisk AS | 31.07.2026 0 Monate | 31.07.2026 | 0 Monate | 307,60 250 | 307,60 | 250 | 18,725618 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 307,60 290 | 307,60 | 290 | 5,721717 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 10.07.2026 0 Monate | 10.07.2026 | 0 Monate | 307,60 332 | 307,60 | 332 | 7,93238 | UBS | ||
| Novo Nordisk AS | 29.06.2026 12 Monate | 29.06.2026 | 12 Monate | 307,60 285 | 307,60 | 285 | 7,347204 | JEFFERIES | ||
| Novo Nordisk AS | 28.06.2026 0 Monate | 28.06.2026 | 0 Monate | 307,60 250 | 307,60 | 250 | 18,725618 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 307,60 290 | 307,60 | 290 | 5,721717 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 16.06.2026 0 Monate | 16.06.2026 | 0 Monate | 307,60 325 | 307,60 | 325 | 5,656697 | BERENBERG | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 307,60 290 | 307,60 | 290 | 5,721717 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 08.06.2026 0 Monate | 08.06.2026 | 0 Monate | 307,60 250 | 307,60 | 250 | 18,725618 | JPMORGAN | ||
| Novo Nordisk AS | 08.06.2026 0 Monate | 08.06.2026 | 0 Monate | 307,60 250 | 307,60 | 250 | 18,725618 | JPMORGAN | ||
| Novo Nordisk AS | 03.06.2026 12 Monate | 03.06.2026 | 12 Monate | 307,60 305 | 307,60 | 305 | 0,845254 | GOLDMAN SACHS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 29.05.2026 0 Monate | 29.05.2026 | 0 Monate | 307,60 270 | 307,60 | 270 | 12,223667 | JEFFERIES | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 307,60 290 | 307,60 | 290 | 5,721717 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 307,60 290 | 307,60 | 290 | 5,721717 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 18.05.2026 0 Monate | 18.05.2026 | 0 Monate | 307,60 300 | 307,60 | 300 | 2,470741 | BARCLAYS | ||
| Novo Nordisk AS | 12.05.2026 12 Monate | 12.05.2026 | 12 Monate | 307,60 270 | 307,60 | 270 | 12,223667 | JEFFERIES | ||
| Novo Nordisk AS | 11.05.2026 12 Monate | 11.05.2026 | 12 Monate | 307,60 175 | 307,60 | 175 | 43,107932 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 307,60 290 | 307,60 | 290 | 5,721717 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 307,60 290 | 307,60 | 290 | 5,721717 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 307,60 | 307,60 | -- | DZ BANK | |||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 307,60 300 | 307,60 | 300 | 2,470741 | BARCLAYS | ||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 307,60 332 | 307,60 | 332 | 7,93238 | UBS | ||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 307,60 250 | 307,60 | 250 | 18,725618 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 06.05.2026 12 Monate | 06.05.2026 | 12 Monate | 307,60 263 | 307,60 | 263 | 14,49935 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 307,60 250 | 307,60 | 250 | 18,725618 | JPMORGAN | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 307,60 175 | 307,60 | 175 | 43,107932 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 307,60 300 | 307,60 | 300 | 2,470741 | BARCLAYS | ||
| Novo Nordisk AS | 29.04.2026 12 Monate | 29.04.2026 | 12 Monate | 307,60 250 | 307,60 | 250 | 18,725618 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 307,60 275 | 307,60 | 275 | 10,598179 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 307,60 270 | 307,60 | 270 | 12,223667 | JEFFERIES | ||
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 307,60 250 | 307,60 | 250 | 18,725618 | JPMORGAN | ||
| Novo Nordisk AS | 15.04.2026 12 Monate | 15.04.2026 | 12 Monate | 307,60 270 | 307,60 | 270 | 12,223667 | JEFFERIES | ||
| Novo Nordisk AS | 09.04.2026 0 Monate | 09.04.2026 | 0 Monate | 307,60 332 | 307,60 | 332 | 7,93238 | UBS | ||
| Novo Nordisk AS | 01.04.2026 0 Monate | 01.04.2026 | 0 Monate | 307,60 270 | 307,60 | 270 | 12,223667 | BARCLAYS | ||
| Novo Nordisk AS | 31.03.2026 12 Monate | 31.03.2026 | 12 Monate | 307,60 263 | 307,60 | 263 | 14,49935 | GOLDMAN SACHS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 30.03.2026 0 Monate | 30.03.2026 | 0 Monate | 307,60 270 | 307,60 | 270 | 12,223667 | BARCLAYS | ||
| Novo Nordisk AS | 29.03.2026 0 Monate | 29.03.2026 | 0 Monate | 307,60 250 | 307,60 | 250 | 18,725618 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 307,60 275 | 307,60 | 275 | 10,598179 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.03.2026 0 Monate | 26.03.2026 | 0 Monate | 307,60 270 | 307,60 | 270 | 12,223667 | BARCLAYS | ||
| Novo Nordisk AS | 25.03.2026 0 Monate | 25.03.2026 | 0 Monate | 307,60 250 | 307,60 | 250 | 18,725618 | JPMORGAN | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 307,60 270 | 307,60 | 270 | 12,223667 | JEFFERIES | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 307,60 270 | 307,60 | 270 | 12,223667 | BARCLAYS | ||
| Novo Nordisk AS | 11.03.2026 0 Monate | 11.03.2026 | 0 Monate | 307,60 300 | 307,60 | 300 | 2,470741 | BERENBERG | ||
| Novo Nordisk AS | 09.03.2026 0 Monate | 09.03.2026 | 0 Monate | 307,60 250 | 307,60 | 250 | 18,725618 | JPMORGAN | ||
| Novo Nordisk AS | 06.03.2026 12 Monate | 06.03.2026 | 12 Monate | 307,60 270 | 307,60 | 270 | 12,223667 | BARCLAYS | ||
| Novo Nordisk AS | 02.03.2026 12 Monate | 02.03.2026 | 12 Monate | 307,60 260 | 307,60 | 260 | 15,474642 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 02.03.2026 0 Monate | 02.03.2026 | 0 Monate | 307,60 270 | 307,60 | 270 | 12,223667 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 27.02.2026 12 Monate | 27.02.2026 | 12 Monate | 307,60 270 | 307,60 | 270 | 12,223667 | BARCLAYS | ||
| Novo Nordisk AS | 24.02.2026 12 Monate | 24.02.2026 | 12 Monate | 307,60 400 | 307,60 | 400 | 30,039012 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.02.2026 0 Monate | 24.02.2026 | 0 Monate | 307,60 250 | 307,60 | 250 | 18,725618 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 307,60 400 | 307,60 | 400 | 30,039012 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 307,60 332 | 307,60 | 332 | 7,93238 | UBS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 307,60 340 | 307,60 | 340 | 10,53316 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 307,60 275 | 307,60 | 275 | 10,598179 | JEFFERIES | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 307,60 350 | 307,60 | 350 | 13,784135 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 307,60 340 | 307,60 | 340 | 10,53316 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 307,60 275 | 307,60 | 275 | 10,598179 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 307,60 250 | 307,60 | 250 | 18,725618 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 307,60 270 | 307,60 | 270 | 12,223667 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 307,60 340 | 307,60 | 340 | 10,53316 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 307,60 340 | 307,60 | 340 | 10,53316 | BARCLAYS | ||
| Novo Nordisk AS | 17.02.2026 0 Monate | 17.02.2026 | 0 Monate | 307,60 340 | 307,60 | 340 | 10,53316 | BARCLAYS | ||
| Novo Nordisk AS | 12.02.2026 0 Monate | 12.02.2026 | 0 Monate | 307,60 340 | 307,60 | 340 | 10,53316 | BARCLAYS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 307,60 400 | 307,60 | 400 | 30,039012 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 307,60 275 | 307,60 | 275 | 10,598179 | JEFFERIES | ||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 307,60 360 | 307,60 | 360 | 17,035111 | BERENBERG | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 307,60 360 | 307,60 | 360 | 17,035111 | BARCLAYS | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 307,60 360 | 307,60 | 360 | 17,035111 | BARCLAYS | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 307,60 350 | 307,60 | 350 | 13,784135 | JPMORGAN | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 307,60 332 | 307,60 | 332 | 7,93238 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 307,60 475 | 307,60 | 475 | 54,421326 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 307,60 332 | 307,60 | 332 | 7,93238 | UBS | ||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 307,60 350 | 307,60 | 350 | 13,784135 | JPMORGAN | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 307,60 270 | 307,60 | 270 | 12,223667 | JEFFERIES | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 307,60 350 | 307,60 | 350 | 13,784135 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 307,60 350 | 307,60 | 350 | 13,784135 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 307,60 360 | 307,60 | 360 | 17,035111 | BARCLAYS | ||
| Novo Nordisk AS | 01.02.2026 0 Monate | 01.02.2026 | 0 Monate | 307,60 390 | 307,60 | 390 | 26,788036 | UBS | ||
| Novo Nordisk AS | 29.01.2026 0 Monate | 29.01.2026 | 0 Monate | 307,60 350 | 307,60 | 350 | 13,784135 | JPMORGAN | ||
| Novo Nordisk AS | 23.01.2026 12 Monate | 23.01.2026 | 12 Monate | 307,60 270 | 307,60 | 270 | 12,223667 | JEFFERIES | ||
| Novo Nordisk AS | 22.01.2026 12 Monate | 22.01.2026 | 12 Monate | 307,60 436 | 307,60 | 436 | 41,742523 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 22.01.2026 0 Monate | 22.01.2026 | 0 Monate | 307,60 415 | 307,60 | 415 | 34,915475 | BERENBERG | ||
| Novo Nordisk AS | 21.01.2026 12 Monate | 21.01.2026 | 12 Monate | 307,60 360 | 307,60 | 360 | 17,035111 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 20.01.2026 12 Monate | 20.01.2026 | 12 Monate | 307,60 270 | 307,60 | 270 | 12,223667 | JEFFERIES | ||
| Novo Nordisk AS | 20.01.2026 0 Monate | 20.01.2026 | 0 Monate | 307,60 390 | 307,60 | 390 | 26,788036 | UBS | ||
| Novo Nordisk AS | 19.01.2026 0 Monate | 19.01.2026 | 0 Monate | 307,60 390 | 307,60 | 390 | 26,788036 | UBS | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 307,60 360 | 307,60 | 360 | 17,035111 | BARCLAYS | ||
| Novo Nordisk AS | 15.01.2026 0 Monate | 15.01.2026 | 0 Monate | 307,60 415 | 307,60 | 415 | 34,915475 | BERENBERG | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 307,60 475 | 307,60 | 475 | 54,421326 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 307,60 350 | 307,60 | 350 | 13,784135 | JPMORGAN | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 307,60 390 | 307,60 | 390 | 26,788036 | UBS | ||
| Novo Nordisk AS | 09.01.2026 12 Monate | 09.01.2026 | 12 Monate | 307,60 400 | 307,60 | 400 | 30,039012 | BERENBERG | ||
| Novo Nordisk AS | 07.01.2026 12 Monate | 07.01.2026 | 12 Monate | 307,60 400 | 307,60 | 400 | 30,039012 | BERENBERG | ||
| Novo Nordisk AS | 06.01.2026 12 Monate | 06.01.2026 | 12 Monate | 307,60 360 | 307,60 | 360 | 17,035111 | BARCLAYS | ||
| Novo Nordisk AS | 02.01.2026 0 Monate | 02.01.2026 | 0 Monate | 307,60 350 | 307,60 | 350 | 13,784135 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 12 Monate | 12 Monate | 307,60 475 | 307,60 | 475 | 54,421326 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 16.12.2025 12 Monate | 16.12.2025 | 12 Monate | 307,60 350 | 307,60 | 350 | 13,784135 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 307,60 475 | 307,60 | 475 | 54,421326 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 12.12.2025 0 Monate | 12.12.2025 | 0 Monate | 307,60 295 | 307,60 | 295 | 4,096229 | UBS |
News
Aktuell
| Datum | Terminart Information | Information |
|---|---|---|
| 05.08.2026 | Bericht zum 2. Quartal Novo Nordisk A/S: Second quarter 2026 | Novo Nordisk A/S: Second quarter 2026 |
| 04.11.2026 | Bericht zum 3. Quartal Novo Nordisk A/S: Third quarter 2026 | Novo Nordisk A/S: Third quarter 2026 |
Anlage-Spezial Europäische Aktien
28.05.2026
Novo Nordisk: KI und Amycretin zünden nächste Pipeline-Stufe
KI beschleunigt die Wirkstoffforschung von Novo Nordisk erheblich. Neue Tabletten wie Amycretin sichern dabei die künftige Marktdominanz ab.
DZ BANK Produktauswahl
Endlos Turbos Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Optionsscheine Classic Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
Abstand zum Basispreis in %
Max
Endlos Turbos Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Discount Classic
Produktauswahl : Basiswert Novo Nordisk AS
Min
Discount in %
Max
Mini-Futures Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Knock Out Map
- wertpapiere@dzbank.de (069) 7447-7035
-
DZ BANK AG, Platz der Republik,
60265 Frankfurt / M